Connect your AI

EXOZ EXOZ Change in Other Assets

Change in Other Assets at other companies

GevoGEVO

-$1.6M-171%

Ginkgo BioworksDNA

-$94K-156%

NAG

Niagen Bioscience, Inc. Common StockNAGE

$169K+945%

Nature's Sunshine ProductsNATR

$3.33M+168%

Opko HealthOPK

-$6.97M-155%

UpexiUPXI

$1.38M+910%

Other financials

Income statement

Revenue$17.5K—

Operating income-$2.4M-22.4%

Net income-$2.4M-27.7%

EPS (diluted)-$0.28-27.3%

Balance sheet

Cash & equivalents$1.4M-83.0%

Total debt$1.2M-8.8%

Total equity$1.5M-82.8%

Total assets$4.0M-65.1%

Cash flow

Operating cash flow-$1.5M-34.5%

CapEx$57.6K+85.5%

Free cash flow-$1.6M-35.8%

Valuation

Market cap$76.8M-5.6%

Enterprise value$76.57M+1.0%

P/S1,096.1×—

Profitability

Operating margin-14,489.6%—

Net margin-2,909.1%—

FCF margin-10,117.8%—

Returns & leverage

Return on equity-185.8%—

Debt / equity0.8×+0.6×

Current ratio1.3×-5.2×

Where this comes from

Reported directly by EXOZ in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is EXOZ's change in other assets?: EXOZ (EXOZ) reported change in other assets of -$40.34K in Q1 2026.
How has EXOZ's change in other assets changed year-over-year?: EXOZ's change in other assets increased by 21.8% year-over-year, from -$51.58K to -$40.34K.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.